Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan DOI Creative Commons
Kazuhiko Iijima,

Hitomi Osako,

Kentaro Iwata

и другие.

Infection Control and Hospital Epidemiology, Год журнала: 2024, Номер unknown, С. 1 - 9

Опубликована: Окт. 22, 2024

Abstract Objective: To compare the effectiveness of universal admission testing (UAT) and risk-based (RBT) in preventing nosocomial coronavirus disease 2019 (COVID-19) after implementation strict infection control measures. Design: Retrospective multicenter cohort study. Setting: Five community hospitals Japan. Patients: 14,028 adult patients admitted emergently from June 1, 2022, to January 31, 2023. Methods: We calculated crude incidence density rates community-acquired COVID-19 (positive test ≤4 days postadmission), hospital-acquired ≥8 total postadmission (all cases positive primary (sporadic index cases). A generalized estimating equation model was used adjust for local (new per 100,000 population), single-bed room proportion, proportion older than 65 years. Results: The weekly study areas less 1,800 population (1.8%). Two implemented RBT 3 UAT. median rate higher UAT group (95% vs 55%; difference 45.2%, 95% CI, 40.3%–48.8%). Crude adjusted analyses revealed no significant associations between (IRR; >1 indicates with UAT) strategies any outcomes: (adjusted IRR = 1.23; 0.46–3.31), (1.46; 0.80–2.66), (1.22; 0.79–1.87), (0.81; 0.59–1.12). Conclusions: Compared testing, may have limited additional benefits transmission during a period low-moderate incidence.

Язык: Английский

The effectiveness and efficiency of asymptomatic SARS-CoV-2 testing strategies for patient and healthcare workers within acute NHS hospitals during an omicron-like period DOI Creative Commons
Stephanie Evans, Nichola R. Naylor, Tom Fowler

и другие.

BMC Infectious Diseases, Год журнала: 2024, Номер 24(1)

Опубликована: Янв. 8, 2024

Asymptomatic SARS-CoV-2 testing of hospitalised patients began in April-2020, with twice weekly healthcare worker (HCW) introduced November-2020. Guidance recommending asymptomatic was withdrawn August-2022. Assessing the impact this decision from data alone is challenging due to concurrent changes infection prevention and control practices, community transmission rates, a reduction ascertainment rate reduced testing. Computational modelling an effective tool for estimating change.

Язык: Английский

Процитировано

5

Evaluating pooled testing for asymptomatic screening of healthcare workers in hospitals DOI Creative Commons
Bethany Heath, Stephanie Evans, David S. Robertson

и другие.

BMC Infectious Diseases, Год журнала: 2023, Номер 23(1)

Опубликована: Дек. 21, 2023

There is evidence that during the COVID pandemic, a number of patient and HCW infections were nosocomial. Various measures put in place to try reduce these including developing asymptomatic PCR (polymerase chain reaction) testing schemes for healthcare workers. Regularly all workers requires many tests while reducing this by only some can result undetected cases. An efficient way test as individuals possible with limited capacity consider pooling multiple samples be analysed single (known pooled testing).

Язык: Английский

Процитировано

3

Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan DOI Creative Commons
Kazuhiko Iijima,

Hitomi Osako,

Kentaro Iwata

и другие.

Infection Control and Hospital Epidemiology, Год журнала: 2024, Номер unknown, С. 1 - 9

Опубликована: Окт. 22, 2024

Abstract Objective: To compare the effectiveness of universal admission testing (UAT) and risk-based (RBT) in preventing nosocomial coronavirus disease 2019 (COVID-19) after implementation strict infection control measures. Design: Retrospective multicenter cohort study. Setting: Five community hospitals Japan. Patients: 14,028 adult patients admitted emergently from June 1, 2022, to January 31, 2023. Methods: We calculated crude incidence density rates community-acquired COVID-19 (positive test ≤4 days postadmission), hospital-acquired ≥8 total postadmission (all cases positive primary (sporadic index cases). A generalized estimating equation model was used adjust for local (new per 100,000 population), single-bed room proportion, proportion older than 65 years. Results: The weekly study areas less 1,800 population (1.8%). Two implemented RBT 3 UAT. median rate higher UAT group (95% vs 55%; difference 45.2%, 95% CI, 40.3%–48.8%). Crude adjusted analyses revealed no significant associations between (IRR; >1 indicates with UAT) strategies any outcomes: (adjusted IRR = 1.23; 0.46–3.31), (1.46; 0.80–2.66), (1.22; 0.79–1.87), (0.81; 0.59–1.12). Conclusions: Compared testing, may have limited additional benefits transmission during a period low-moderate incidence.

Язык: Английский

Процитировано

0